Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes. / Bech, Sara; Hjermind, Lena E; Salvesen, Lisette; Nielsen, Jørgen E; Heegaard, Niels H H; Jørgensen, Henrik L; Rosengren, Lars; Blennow, Kaj; Zetterberg, Henrik; Winge, Kristian.

I: Parkinsonism & Related Disorders, Bind 18, Nr. 1, 2012, s. 69-72.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Bech, S, Hjermind, LE, Salvesen, L, Nielsen, JE, Heegaard, NHH, Jørgensen, HL, Rosengren, L, Blennow, K, Zetterberg, H & Winge, K 2012, 'Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes', Parkinsonism & Related Disorders, bind 18, nr. 1, s. 69-72. https://doi.org/10.1016/j.parkreldis.2011.08.012

APA

Bech, S., Hjermind, L. E., Salvesen, L., Nielsen, J. E., Heegaard, N. H. H., Jørgensen, H. L., Rosengren, L., Blennow, K., Zetterberg, H., & Winge, K. (2012). Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes. Parkinsonism & Related Disorders, 18(1), 69-72. https://doi.org/10.1016/j.parkreldis.2011.08.012

Vancouver

Bech S, Hjermind LE, Salvesen L, Nielsen JE, Heegaard NHH, Jørgensen HL o.a. Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes. Parkinsonism & Related Disorders. 2012;18(1):69-72. https://doi.org/10.1016/j.parkreldis.2011.08.012

Author

Bech, Sara ; Hjermind, Lena E ; Salvesen, Lisette ; Nielsen, Jørgen E ; Heegaard, Niels H H ; Jørgensen, Henrik L ; Rosengren, Lars ; Blennow, Kaj ; Zetterberg, Henrik ; Winge, Kristian. / Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes. I: Parkinsonism & Related Disorders. 2012 ; Bind 18, Nr. 1. s. 69-72.

Bibtex

@article{9b1da708114c43b68df5c9567008b7e7,
title = "Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes",
abstract = "Clinical differentiation between parkinsonian syndromes (PS) remains a challenge despite well-established clinical diagnostic criteria. Specific diagnostic biomarkers have yet to be identified, though in recent years, studies have been published on the aid of certain brain related proteins (BRP) in the diagnosing of PS. We investigated the levels of the light subunit of neurofilament triplet protein (NF-L), total tau and phosphorylated tau, amyloid-{\ss}(1-42), and the soluble a- and {\ss}-cleaved fragments of amyloid precursor proteins in a cohort of patients with various PS.",
author = "Sara Bech and Hjermind, {Lena E} and Lisette Salvesen and Nielsen, {J{\o}rgen E} and Heegaard, {Niels H H} and J{\o}rgensen, {Henrik L} and Lars Rosengren and Kaj Blennow and Henrik Zetterberg and Kristian Winge",
note = "Copyright {\textcopyright} 2011 Elsevier Ltd. All rights reserved.",
year = "2012",
doi = "10.1016/j.parkreldis.2011.08.012",
language = "English",
volume = "18",
pages = "69--72",
journal = "Parkinsonism & Related Disorders",
issn = "1353-8020",
publisher = "Elsevier",
number = "1",

}

RIS

TY - JOUR

T1 - Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes

AU - Bech, Sara

AU - Hjermind, Lena E

AU - Salvesen, Lisette

AU - Nielsen, Jørgen E

AU - Heegaard, Niels H H

AU - Jørgensen, Henrik L

AU - Rosengren, Lars

AU - Blennow, Kaj

AU - Zetterberg, Henrik

AU - Winge, Kristian

N1 - Copyright © 2011 Elsevier Ltd. All rights reserved.

PY - 2012

Y1 - 2012

N2 - Clinical differentiation between parkinsonian syndromes (PS) remains a challenge despite well-established clinical diagnostic criteria. Specific diagnostic biomarkers have yet to be identified, though in recent years, studies have been published on the aid of certain brain related proteins (BRP) in the diagnosing of PS. We investigated the levels of the light subunit of neurofilament triplet protein (NF-L), total tau and phosphorylated tau, amyloid-ß(1-42), and the soluble a- and ß-cleaved fragments of amyloid precursor proteins in a cohort of patients with various PS.

AB - Clinical differentiation between parkinsonian syndromes (PS) remains a challenge despite well-established clinical diagnostic criteria. Specific diagnostic biomarkers have yet to be identified, though in recent years, studies have been published on the aid of certain brain related proteins (BRP) in the diagnosing of PS. We investigated the levels of the light subunit of neurofilament triplet protein (NF-L), total tau and phosphorylated tau, amyloid-ß(1-42), and the soluble a- and ß-cleaved fragments of amyloid precursor proteins in a cohort of patients with various PS.

U2 - 10.1016/j.parkreldis.2011.08.012

DO - 10.1016/j.parkreldis.2011.08.012

M3 - Journal article

C2 - 21873100

VL - 18

SP - 69

EP - 72

JO - Parkinsonism & Related Disorders

JF - Parkinsonism & Related Disorders

SN - 1353-8020

IS - 1

ER -

ID: 38425969